Last reviewed · How we verify
Autologous Conditioned Serum
Autologous Conditioned Serum is a treatment that uses a patient's own blood to stimulate healing and reduce inflammation.
Autologous Conditioned Serum is a treatment that uses a patient's own blood to stimulate healing and reduce inflammation. Used for Osteoarthritis, Rheumatoid Arthritis.
At a glance
| Generic name | Autologous Conditioned Serum |
|---|---|
| Also known as | ACS, Orthokine® |
| Sponsor | Ospedale San Raffaele |
| Modality | Small molecule |
| Therapeutic area | Regenerative Medicine |
| Phase | Phase 2 |
Mechanism of action
The serum is collected from the patient's own blood, which is then used to stimulate the body's natural healing processes. This can help to reduce inflammation and promote tissue repair.
Approved indications
- Osteoarthritis
- Rheumatoid Arthritis
Common side effects
- Pain
- Swelling
- Infection
Key clinical trials
- Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study (PHASE1, PHASE2)
- Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS) (NA)
- Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder (NA)
- Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia (PHASE1, PHASE2)
- Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas (PHASE1, PHASE2)
- Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias (PHASE1, PHASE2)
- Stem Cell Transplantation in Crohn's Disease (PHASE1, PHASE2)
- GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |